Concepedia

Adam Sheehy

AS

Statistics

Publications

4

Citations

1K

H-Index

4

Active since

2008

Affiliations

Biogen (United States)(Current)

AstraZeneca (United States)

Adam Sheehy is an author at Biogen (United States) specializing in life sciences, molecular neuroscience, and neurodegenerative disorders.

ORCID

Publications per year

2008–2022

4

Publications

4

The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors

Michael Hedvat, Dennis Huszar, Andreas Herrmann et al. · Cancer Cell · 2009 · 529 citations · Full text

, , +9

AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies

Sonya Zabludoff, Chun Deng, Michael Grondine et al. · Molecular Cancer Therapeutics · 2008 · 410 citations · Full text

, , +17

Dimethyl fumarate alters microglia phenotype and protects neurons against proinflammatory toxic microenvironments

Haiyan Peng, Li Huo, Adam Sheehy et al. · Journal of Neuroimmunology · 2016 · 51 citations

, , +14

In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model

Yi A. Chen, Mark W. Kankel, Sam Hana et al. · Gene Therapy · 2022 · 27 citations · Full text

, , +14

1–4 of 4